OMER-DECUGIS & CIE (EPA:ALODC) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
OMER-DECUGIS & CIE

BRIEF

published on 10/29/2024 at 18:05, 1 year 1 month ago

Omer-Decugis & Cie wins a major project at the port of Dunkirk

Logistics Agri-food Dunkirk Platform Omer-Decugis & Co.
PRESS RELEASE

published on 10/29/2024 at 18:00, 1 year 1 month ago

Omer-Decugis and Cie wins the call for proposals launched by the Major Maritime Port of Dunkirk for the construction of a logistics and ripening platform in 2027
Omer-Decugis & Cie wins call for proposals by Major Maritime Port of Dunkirk to build new logistics and ripening platform in 2027, doubling capacity and aligning with sustainable development goals

Sustainable Development Logistics Platform Omer-Decugis & Cie Ripening Rooms Port Of Dunkirk
BRIEF

published on 10/24/2024 at 18:05, 1 year 1 month ago

Change of Date for the Annual Turnover of Omer-Decugis & Cie

Financial Agenda Turnover Fruits And Vegetables Rungis Omer-Decugis & Co.
PRESS RELEASE

published on 10/24/2024 at 18:00, 1 year 1 month ago

Change of the financial agenda
Omer-Decugis & Cie announces a change in its financial calendar, with FY 2023/24 revenue to be published on November 4, 2024, rather than November 5. The group specializes in fresh and exotic fruit and vegetables, with a focus on sustainable agriculture

Financial Calendar Sustainable Agriculture Omer-Decugis & Cie Exotic Fruit FY 2023/24 Revenue
BRIEF

published on 07/17/2024 at 18:20, 1 year 4 months ago

Omer-Decugis & Cie Reports Robust H1 2023/24 Growth

EBITDA Revenue Growth Financial Outlook Omer-Decugis & Cie H1 2023/24 Results
PRESS RELEASE

published on 07/17/2024 at 18:15, 1 year 4 months ago

Solid first half 2023/24 results and healthy outlook with continued growth in Q3 2023/24
Omer-Decugis & Cie reports strong first-half revenue growth of 18.3% with a 3.5% EBITDA margin. Positive outlook supported by 15.3% revenue growth in Q3 2023/24, aligning with 2025 targets

Financial Results Revenue Growth EBITDA Margin Omer-Decugis & Cie 2025 Targets
BRIEF

published on 05/13/2024 at 18:05, 1 year 6 months ago

Omer-Decugis & Cie posts solid growth in the first half of 2023/24

Acquisitions Financial Growth Omer-Decugis & Cie Fruits And Vegetables Exotic Market
PRESS RELEASE

published on 05/13/2024 at 18:00, 1 year 6 months ago

Omer-Decugis and Cie posts an excellent first half 2023/24 with revenue up sharply by 18.5% to EUR 123.8 million
Omer-Decugis & Cie reports strong revenue growth in H1 2023/24, up 18.5% to €123.8 million, driven by strategic acquisitions and product development across divisions

Revenue Growth Acquisitions Product Development Omer-Decugis & Cie H1 2023/24
BRIEF

published on 05/07/2024 at 14:05, 1 year 6 months ago

Resumption of imports of mangoes from West Africa to the port of Dunkirk

SIIM Omer-Decugis & Cie Mangoes Dunkirk Import

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 28 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 33 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 3 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 58 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 3 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 33 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 12 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 38 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 48 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 53 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 3 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 18 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 2 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE